KC
Kroeger Christopher A.
CEOM
Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Kroeger Christopher A.. Officer active across 1 company, notably MapLight Therapeutics, Inc.. Cumulatively, 14 disclosures have been logged. Split: 0 buy · 10 sells. Total volume traded: €5.2m. History available since 27 October 2025. The latest transaction was filed on 17 August 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Kroeger Christopher A.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
23,145 shares0Voting Common StockSEC:0001658918-26-000016:0
42,738 shares@ US$36.990.092% mcap10.4% of flowVoting Common StockSEC:0001658918-26-000014:1
16,779 shares@ US$37.900.037% mcap4.2% of flowVoting Common StockSEC:0001658918-26-000014:6
90 shares@ US$37.540.0002% mcap0.0% of flowVoting Common StockSEC:0001658918-26-000014:2
28,091 shares@ US$37.260.061% mcap6.8% of flowVoting Common StockSEC:0001658918-26-000014:4
40,899 shares@ US$36.460.087% mcap9.8% of flowVoting Common StockSEC:0001658918-26-000014:3
18,950 shares@ US$36.000.040% mcap4.5% of flowVoting Common StockSEC:0001658918-26-000014:0
92 shares@ US$37.960.0002% mcap0.0% of flowVoting Common StockSEC:0001658918-26-000014:5
9,135 shares@ US$26.930.015% mcap47.1% of flowVoting Common StockSEC:0001658918-26-000006:0
2,477 shares@ US$27.010.0041% mcap12.9% of flowVoting Common StockSEC:0001658918-26-000006:1
7,575 shares@ US$27.490.013% mcap40.0% of flowVoting Common StockSEC:0001658918-26-000006:2
23,145 shares0Voting Common StockSEC:0001658918-26-000004:0
204,146 shares@ US$17.9887.5% of flowVoting Common StockSEC:0001658918-26-000002:0
225,693 shares0Voting Common StockSEC:0001658918-25-000008:0
About Kroeger Christopher A.
Kroeger Christopher A. is a declarant linked to MapLight Therapeutics, Inc., where he is Chief Executive Officer. The 13 filings in the recent sample cover the period from 2025-10-28 to 2026-07-17, with EUR 0 in purchases and EUR 5194314 in sales, and the most frequent transaction nature is sell.